Javier Cortés, Angel Guerrero-Zotano, María Gion, Cristina Alba Torres, Luis De La Cruz, Ana López González, Jose Juan Ponce-Lorenzo, Michael Untch, Carmen Mora Gallardo, Michela Verbeni, Mireia Pedragosa, Janat Fazal-Salom, Maryna Todoriuk, José Manuel Pérez García, Antonio Llombart-Cussac. "Camizestrant plus ribociclib in hormone receptor–positive/HER2-negative advanced breast cancer: The phase II CADILLAC trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1150